Alternatives to NanoStruct

Pioneering sustainable oils and fats through fermentation.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Ensilitech develops innovative solutions for the detection and analysis of foodborne pathogens and contaminants.

Enzyme-based technology to break down alcohol in the stomach.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered precision testing for patient identification in clinics and clinical trials.

Developing AI-powered diagnostics for neurodegenerative diseases.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Pioneering Liquid State Intelligence for physical-world AI.

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Wearable chip that analyzes proteins and hormones in real time.

Europe's first cultivated meat company, focused on scalable and affordable production.

Discovering and developing novel, high-value ingredients for food and health.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation.

Developing breath-based diagnostics for lung diseases.

A biotechnology company focused on genetically engineered salmon for sustainable aquaculture.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing an automated platform for liquid biopsy sample preparation.

Developing vegan cheese that mimics the taste, feel, and cost of dairy cheese.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Bosque Foods creates nutrient-dense, clean-label whole-cut meat alternatives from mycelium, the root structure of mushrooms.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A leading organization dedicated to curing and treating cystic fibrosis.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Accelerating patient access to evidence-based innovation in mental health.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing gene editing therapies to lower cholesterol.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.